COVID-19 疫苗接种：利用 VigiBase 数据观察动脉和静脉血栓形成的发生情况。
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.
机构信息
Université de Paris, Innovative Therapies in Hemostasis, INSERM, Paris, France
Hematology Dept and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
出版信息
Eur Respir J. 2021 Jul 1;58(1). doi: 10.1183/13993003.00956-2021. Print 2021 Jul.
Abstract
摘要
[链接]
相似文献
1
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.COVID-19 疫苗接种：利用 VigiBase 数据观察动脉和静脉血栓形成的发生情况。
Eur Respir J. 2021 Jul 1;58(1). doi: 10.1183/13993003.00956-2021. Print 2021 Jul.
2
Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?新冠病毒疫苗接种后的脑静脉血栓形成：通过血管内接种疫苗会增加血栓形成风险吗？
Infection. 2021 Oct;49(5):1071-1074. doi: 10.1007/s15010-021-01658-x. Epub 2021 Jul 21.
3
Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?脑静脉血栓形成与新冠病毒疫苗接种的发生率：可能的因果关系还是纯属巧合？
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e77-e78. doi: 10.1093/ehjcvp/pvab036.
4
Deep vein thrombosis more than two weeks after vaccination against COVID-19.接种新冠疫苗两周多后发生深静脉血栓形成。
Tidsskr Nor Laegeforen. 2021 Apr 28;141. doi: 10.4045/tidsskr.21.0274. Print 2021 Apr 29.
5
The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2.国际脑静脉血栓形成联盟关于接种新冠病毒疫苗后脑静脉血栓形成的报告。
Eur J Neurol. 2021 Nov;28(11):3543-3544. doi: 10.1111/ene.15085. Epub 2021 Sep 14.
6
Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination.新冠病毒疫苗接种后发生的脑静脉血栓形成和血小板减少症
Thromb Res. 2021 Jun;202:182-183. doi: 10.1016/j.thromres.2021.04.001. Epub 2021 Apr 8.
7
Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.增加抗凝治疗可降低机械通气的新冠肺炎患者近端深静脉血栓形成风险：静脉血栓预防与新冠肺炎
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.11.019. Epub 2020 Nov 20.
8
COVID-19 vaccination prevents venous thrombosis in patients with SARS-CoV-2 infection and thereafter.新冠病毒疫苗接种可预防感染新冠病毒及后续患者的静脉血栓形成。
Blood Coagul Fibrinolysis. 2024 Jul 1;35(5):225-226. doi: 10.1097/MBC.0000000000001310. Epub 2024 Jul 5.
9
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis: Response from original authors Pola et al.尽管进行了药物性血栓预防，因新冠肺炎住院的非重症监护病房患者深静脉血栓形成的发生率：原作者波拉等人的回应
J Thromb Haemost. 2020 Nov;18(11):3110-3111. doi: 10.1111/jth.15089.
10
Cerebral Venous Thrombosis following COVID-19 Vaccination.新冠疫苗接种后的脑静脉血栓形成
J Stroke Cerebrovasc Dis. 2021 Oct;30(10):105866. doi: 10.1016/j.jstrokecerebrovasdis.2021.105866. Epub 2021 May 10.
引用本文的文献
1
The early impact of COVID-19 vaccines on major events in cardiac, pulmonary, and thromboembolic disease: a population-based study.新冠病毒疫苗对心脏、肺部和血栓栓塞性疾病重大事件的早期影响：一项基于人群的研究。
Korean J Intern Med. 2025 Sep;40(5):801-812. doi: 10.3904/kjim.2025.056. Epub 2025 Aug 26.
2
Vaccines Against Urban Epidemic Arboviruses: The State of the Art.针对城市流行性虫媒病毒的疫苗：现状
Viruses. 2025 Mar 6;17(3):382. doi: 10.3390/v17030382.
3
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.抗血小板因子4/肝素抗体与血小板活化在全身性炎症性疾病和血栓形成疾病中的相关性：来自COVID-19大流行的见解
Res Pract Thromb Haemost. 2025 Feb 9;9(1):102701. doi: 10.1016/j.rpth.2025.102701. eCollection 2025 Jan.
4
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.2019年冠状病毒病（COVID-19）原始单价信使核糖核酸疫苗接种系列预防COVID-19相关静脉血栓栓塞症住院的有效性
J Infect Dis. 2025 Feb 20;231(2):378-385. doi: 10.1093/infdis/jiae502.
5
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.新型冠状病毒肺炎（COVID-19）的全面综述：流行病学、发病机制、诊断和检测技术的进展，以及大流行后的治疗策略。
Int J Mol Sci. 2024 Jul 26;25(15):8155. doi: 10.3390/ijms25158155.
6
Case report: A case of unilateral combined central retinal vein occlusion, incomplete central retinal artery occlusion, and papillitis following a third dose of COVID-19 vaccination.病例报告：1例在接种第三剂新冠病毒疫苗后出现单侧视网膜中央静脉联合阻塞、视网膜中央动脉不完全阻塞及视乳头炎的病例。
Front Ophthalmol (Lausanne). 2024 Feb 23;4:1352962. doi: 10.3389/fopht.2024.1352962. eCollection 2024.
7
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).新冠病毒疫苗接种后的间质性肺病：利用全球药物警戒数据库（VigiBase）进行的比例失调分析。
BMJ Open Respir Res. 2023 Dec 11;10(1):e001992. doi: 10.1136/bmjresp-2023-001992.
8
Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations.新冠病毒疫苗和流感疫苗接种后静脉血栓栓塞结局的比较
TH Open. 2023 Dec 4;7(4):e303-e308. doi: 10.1055/a-2183-5269. eCollection 2023 Oct.
9
ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review.ChAdOx1新型冠状病毒疫苗与成人血栓形成伴血小板减少综合征：一项系统评价
Adv Pharm Bull. 2023 Nov;13(4):723-735. doi: 10.34172/apb.2023.081. Epub 2023 Apr 29.
10
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.新型冠状病毒2感染和新冠疫苗接种后的血液凝固及血栓形成障碍
Biomedicines. 2023 Oct 17;11(10):2813. doi: 10.3390/biomedicines11102813.
本文引用的文献
1
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
2
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
3
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission.COVID-19 患者住院时肺栓塞的患病率。
Eur Respir J. 2021 Jul 20;58(1). doi: 10.1183/13993003.00116-2021. Print 2021 Jul.
4
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
5
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19（阿斯利康）疫苗免疫原性和有效性的影响：四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
6
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.抗凝治疗是 COVID-19 的潜在保护因素：一项法国多中心队列研究的启示
J Am Heart Assoc. 2021 Apr 20;10(8):e018624. doi: 10.1161/JAHA.120.018624. Epub 2021 Feb 8.
7
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.循环血管性血友病因子和高分子量多聚体作为内皮损伤标志物可预测COVID-19患者的院内死亡率。
Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15.
8
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?内皮细胞功能障碍：在严重急性呼吸综合征冠状病毒 2 感染（COVID-19）中扮演重要角色？
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01634-2020. Print 2020 Jul.
Zotero 插件